EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Onward Medical NV's Enterprise Value is $141.49 Mil.
Onward Medical NV's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-45.92 Mil. Therefore, Onward Medical NV's EV-to-FCF for today is -3.08.
The historical rank and industry rank for Onward Medical NV's EV-to-FCF or its related term are showing as below:
ONWRF'
s EV-to-FCF Range Over the Past 10 Years
Min: -8.16 Med: -4.12 Max: -1.53
Current: -3.27
During the past 9 years, the highest EV-to-FCF of Onward Medical NV was -1.53. The lowest was -8.16. And the median was -4.12.
ONWRF's EV-to-FCF is ranked worse than 100% of 331
companies
in the Biotechnology industry
Industry Median: 15.57
vs ONWRF: -3.27
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Onward Medical NV (OTCPK:ONWRF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Onward Medical NV's PE Ratio (TTM) for today is calculated as:
Onward Medical NV's share price for today is $2.96.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Onward Medical NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.046.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Onward Medical NV EV-to-FCF Related Terms
Onward Medical NV EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Onward Medical NV's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Onward Medical NV's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onward Medical NV EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Onward Medical NV's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Onward Medical NV's EV-to-FCF falls into.
Onward Medical NV's current Enterprise Value is $141.49 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Onward Medical NV's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-45.92 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onward Medical NV (ONWRF) has a EV-to-FCF of -3.08 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Onward Medical NV and its competitors. According to the industry distribution chart, Onward Medical NV ranks #999999 out of 331 companies in the Biotechnology industry.
Is Onward Medical NV's EV-to-FCF too high?
Onward Medical NV's current EV-to-FCF is -3.08. Based on the distribution chart, Onward Medical NV ranks #999999 out of 331 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Onward Medical NV ranks #999999 out of 331 companies for EV-to-FCF. This places Onward Medical NV in the lower half of its industry. The industry median EV-to-FCF is 15.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.57, based on 331 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Onward Medical NV and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onward Medical NV's current EV-to-FCF is -3.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $154.42, compared to a current price of $2.96 — trading 98.1% below its estimated fair value. The current EV-to-FCF is -3.08. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current EV-to-FCF is -3.08 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onward Medical NV (ONWRF) Overvalued in 2026?
Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued.
The current stock price of $2.96 is trading 98.1% below its estimated GF Value™ of $154.42.
GuruFocus considers Onward Medical NV to be Possible Value Trap.
Key valuation signals for ONWRF:
EV-to-FCF: -3.08
GF Value™: $154.42 vs. price of $2.96 (98.1% below fair value)
No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score
Get the complete analysis for ONWRF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ONWRF has been successfully added to your 
